Scientific Publications by FDA Staff
Clin Vaccine Immunol 2011 Aug;18(8):1387-90
Immunogenicity of inactivated polio vaccine with concurrent antiviral v-073 administration in mice.
Kouiavskaia D, Collett MS, Dragunsky EM, Sarafanov A, Chumakov KM
Immunization of mice with inactivated polio vaccine (IPV) with concurrent dosing of poliovirus antiviral V-073 showed no detrimental impact on the elicitation of serum neutralizing antibodies. A strategy involving co-administration of antiviral V-073 and IPV can be considered for the management of poliovirus incidents.
|Category: Journal Article|
|PubMed ID: #21715577||DOI: 10.1128/CVI.05147-11|
|PubMed Central ID: #PMC3147355|
|Includes FDA Authors from Scientific Area(s): Biologics|
|Entry Created: 2011-10-03||Entry Last Modified: 2012-08-29|